Infliximab Rituximab Etanercept Tocilizumab Therapy

Infliximab Rituximab Etanercept Tocilizumab Therapy

Infliximab, rituximab, etanercept or tocilizumab therapy in India for selected immune-mediated disease after diagnosis-specific screening, specialist selection and safety monitoring.

✓Our healthcare experts will be by your side, helping you make the best treatment choice.

Our services are FREE and by using our services your hospital bill does not increase!

About Infliximab Rituximab Etanercept Tocilizumab Therapy

Infliximab, rituximab, etanercept and tocilizumab therapy in India refers to several different biologic medicines used for selected immune-mediated diseases. They are not interchangeable: infliximab and etanercept inhibit TNF, rituximab targets CD20-positive B cells and tocilizumab blocks the IL-6 receptor. The appropriate drug therefore depends on the confirmed diagnosis, previous treatment, disease activity and individual safety factors.

Assessment is led by the relevant specialist, often rheumatology but sometimes gastroenterology, neurology, haematology or another service. Before treatment, teams review previous conventional DMARDs or biologics, vaccination status, tuberculosis and hepatitis risk, blood count and liver and kidney function, with diagnosis-specific imaging or laboratory assessment when required. Rituximab may also require immunoglobulin review in selected patients. Some medicines are given by intravenous infusion while others can be injected subcutaneously, and induction and maintenance schedules differ substantially.

Important risks include serious infection, infusion or injection reactions and medicine-specific adverse effects. Treatment may need to be delayed or reassessed during significant infection. Screening for latent tuberculosis and hepatitis is important before selected biologics, and live vaccines can be inappropriate during some forms of immunosuppression. High fever, severe breathlessness, neurological deterioration or another serious suspected infection requires prompt local medical assessment rather than planned medical travel.

Cost in India depends on the exact biologic or biosimilar, diagnosis, dose and body weight where relevant, infusion versus injection, treatment frequency, pre-treatment screening, laboratory monitoring and hospital or day-care charges. Induction courses and long-term maintenance schedules can therefore have very different total costs.

India has tertiary centres with rheumatology and other diagnosis-specific specialists, biologic infusion facilities, laboratory monitoring and multidisciplinary support. Medical Help India is a connection platform that can connect medically stable international patients with an appropriate healthcare partner to review previous therapy, assess biologic options and provide an individual treatment and cost estimate.

What's Included

Pre-treatment consultation
Diagnostic tests & evaluation
Treatment procedure
Post-treatment care
Hospital stay (if required)
Follow-up consultations

Why consider treatment in India?

Access to experienced specialists

Advanced treatment and diagnostic options

More affordable hospital care

Shorter waiting times for treatment

Help comparing hospitals, plans and costs

Support with appointments, travel and follow-up

Cost in India

USD
$338–901

Final costs depend on the medical assessment, hospital, room category and clinical needs.

Get a Cost Estimate

How it works

1

Share your details

Tell us about your health concerns, age and current location.

2

Receive a call

We call you to discuss your situation, needs and questions.

3

Receive a treatment plan

Get information about the most suitable treatment plan, hospital and estimated cost.

4

Choose your plan

Review the options and agree on your care and travel plan.

5

Get full support

Receive full support throughout every stage of your care journey.

6

Receive care in India

Receive your planned care with support throughout your stay.

Top Hospitals for Infliximab Rituximab Etanercept Tocilizumab Therapy

View All Hospitals →

Top Doctors for Infliximab Rituximab Etanercept Tocilizumab Therapy

View All Doctors →

Frequently Asked Questions

How much does Infliximab Rituximab Etanercept Tocilizumab Therapy cost in India?

Cost depends on the exact biologic or biosimilar, diagnosis, dose and body weight where relevant, infusion versus injection, treatment frequency, pre-treatment screening, laboratory monitoring and hospital or day-care infusion charges. Induction courses and long-term maintenance schedules can have very different total costs.

Which medical reports are useful to have ready for Infliximab Rituximab Etanercept Tocilizumab Therapy?

Have ready: the specialist note confirming the diagnosis, disease-activity assessments, previous conventional DMARD or biologic treatment with response and adverse effects, recent blood count and liver and kidney tests and relevant imaging. Include tuberculosis and hepatitis screening, vaccination history, current medicines and any recent or recurrent infection.

Are infliximab, rituximab, etanercept and tocilizumab interchangeable?

No. They target different immune pathways and have different indications, contraindications and monitoring requirements.

Why is infection screening needed before biologic therapy?

Biologic medicines can increase susceptibility to infection or reactivate latent infections, so tuberculosis, hepatitis and other risks may need assessment.

How is the biologic selected?

Selection depends on the diagnosis, disease activity, previous treatments, comorbidities, infection risk and evidence for the individual drug.

Doctor discussing treatment options with a patient

Our services are FREE

We connect you with leading hospitals and specialists in India. You pay the hospital directly.

TelegramWhatsApp